Biotika a.s. (BSSE:1BSL01AE)

Biotika a.s. Statistics

Total Valuation

Biotika a.s. has a market cap or net worth of EUR 6.30 million. The enterprise value is 4.59 million.

Market Cap	6.30M
Enterprise Value	4.59M

Important Dates

The next estimated earnings date is Tuesday, December 23, 2025.

Earnings Date	Dec 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Biotika a.s. has 700,000 shares outstanding.

Current Share Class	564,936
Shares Outstanding	700,000
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.34
PB Ratio	0.29
P/TBV Ratio	0.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.61
EV / Sales	0.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.89

Financial Position

The company has a current ratio of 4.51, with a Debt / Equity ratio of 0.11.

Current Ratio	4.51
Quick Ratio	2.38
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	-1.54
Interest Coverage	-111.25

Financial Efficiency

Return on equity (ROE) is -12.10% and return on invested capital (ROIC) is -9.70%.

Return on Equity (ROE)	-12.10%
Return on Assets (ROA)	-8.66%
Return on Invested Capital (ROIC)	-9.70%
Return on Capital Employed (ROCE)	-15.50%
Revenue Per Employee	124,406
Profits Per Employee	-19,048
Employee Count	187
Asset Turnover	0.67
Inventory Turnover	2.82

Taxes

Income Tax	-435,490
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.88% in the last 52 weeks. The beta is -0.08, so Biotika a.s.'s price volatility has been lower than the market average.

Beta (5Y)	-0.08
52-Week Price Change	-51.88%
50-Day Moving Average	14.28
200-Day Moving Average	24.14
Relative Strength Index (RSI)	41.54
Average Volume (20 Days)	32

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotika a.s. had revenue of EUR 18.66 million and -2.86 million in losses. Loss per share was -4.08.

Revenue	18.66M
Gross Profit	4.29M
Operating Income	-3.85M
Pretax Income	-3.29M
Net Income	-2.86M
EBITDA	-2.44M
EBIT	-3.85M
Loss Per Share	-4.08

Balance Sheet

The company has 4.15 million in cash and 2.45 million in debt, giving a net cash position of 1.71 million or 2.44 per share.

Cash & Cash Equivalents	4.15M
Total Debt	2.45M
Net Cash	1.71M
Net Cash Per Share	2.44
Equity (Book Value)	21.99M
Book Value Per Share	31.41
Working Capital	7.69M

Cash Flow

In the last 12 months, operating cash flow was -929,623 and capital expenditures -662,463, giving a free cash flow of -1.59 million.

Operating Cash Flow	-929,623
Capital Expenditures	-662,463
Free Cash Flow	-1.59M
FCF Per Share	-2.27

Margins

Gross margin is 22.99%, with operating and profit margins of -20.65% and -15.31%.

Gross Margin	22.99%
Operating Margin	-20.65%
Pretax Margin	-17.64%
Profit Margin	-15.31%
EBITDA Margin	-13.08%
EBIT Margin	-20.65%
FCF Margin	n/a

Dividends & Yields

Biotika a.s. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-45.35%
FCF Yield	-25.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotika a.s. has an Altman Z-Score of 1.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.8
Piotroski F-Score	3